XEROX HOLDINGS CORP (XRX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:XRX • US98421M1062

2.17 USD
-0.13 (-5.65%)
At close: Feb 3, 2026
2.1 USD
-0.07 (-3.23%)
Pre-Market: 2/4/2026, 4:30:51 AM
Fundamental Rating

3

Taking everything into account, XRX scores 3 out of 10 in our fundamental rating. XRX was compared to 34 industry peers in the Technology Hardware, Storage & Peripherals industry. XRX may be in some trouble as it scores bad on both profitability and health. XRX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • XRX had negative earnings in the past year.
  • In the past year XRX had a positive cash flow from operations.
  • XRX had negative earnings in each of the past 5 years.
  • Each year in the past 5 years XRX had a positive operating cash flow.
XRX Yearly Net Income VS EBIT VS OCF VS FCFXRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • With a Return On Assets value of -10.62%, XRX perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • XRX's Return On Equity of -158.51% is on the low side compared to the rest of the industry. XRX is outperformed by 64.71% of its industry peers.
Industry RankSector Rank
ROA -10.62%
ROE -158.51%
ROIC N/A
ROA(3y)-8.9%
ROA(5y)-6.63%
ROE(3y)-87.49%
ROE(5y)-56.4%
ROIC(3y)N/A
ROIC(5y)N/A
XRX Yearly ROA, ROE, ROICXRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • XRX has a Gross Margin of 27.07%. This is comparable to the rest of the industry: XRX outperforms 47.06% of its industry peers.
  • XRX's Gross Margin has declined in the last couple of years.
  • XRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.02%
GM growth 5Y-6.26%
XRX Yearly Profit, Operating, Gross MarginsXRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

2

2. Health

2.1 Basic Checks

  • XRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XRX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, XRX has less shares outstanding
  • Compared to 1 year ago, XRX has a worse debt to assets ratio.
XRX Yearly Shares OutstandingXRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
XRX Yearly Total Debt VS Total AssetsXRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • XRX has an Altman-Z score of 1.11. This is a bad value and indicates that XRX is not financially healthy and even has some risk of bankruptcy.
  • XRX has a Altman-Z score (1.11) which is in line with its industry peers.
  • XRX has a debt to FCF ratio of 31.93. This is a negative value and a sign of low solvency as XRX would need 31.93 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 31.93, XRX is in line with its industry, outperforming 52.94% of the companies in the same industry.
  • A Debt/Equity ratio of 6.10 is on the high side and indicates that XRX has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 6.10, XRX is doing worse than 67.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 6.1
Debt/FCF 31.93
Altman-Z 1.11
ROIC/WACCN/A
WACC4.29%
XRX Yearly LT Debt VS Equity VS FCFXRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

2.3 Liquidity

  • XRX has a Current Ratio of 1.12. This is a normal value and indicates that XRX is financially healthy and should not expect problems in meeting its short term obligations.
  • XRX has a Current ratio (1.12) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.80 indicates that XRX may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.80, XRX is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.8
XRX Yearly Current Assets VS Current LiabilitesXRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

3

3. Growth

3.1 Past

  • XRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -162.50%.
  • XRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.88%.
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.78%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y-0.4%
Revenue growth 5Y0%
Sales Q2Q%25.73%

3.2 Future

  • XRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.51% yearly.
  • Based on estimates for the next years, XRX will show a small growth in Revenue. The Revenue will grow by 1.51% on average per year.
EPS Next Y230.29%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
EPS Next 5YN/A
Revenue Next Year8.62%
Revenue Next 2Y2.6%
Revenue Next 3Y1.51%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XRX Yearly Revenue VS EstimatesXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
XRX Yearly EPS VS EstimatesXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

  • XRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 2.78, the valuation of XRX can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, XRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of XRX to the average of the S&P500 Index (25.51), we can say XRX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.78
XRX Price Earnings VS Forward Price EarningsXRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • XRX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. XRX is cheaper than 73.53% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, XRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.09
EV/EBITDA 15.14
XRX Per share dataXRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • XRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • XRX's earnings are expected to grow with 55.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y98.66%
EPS Next 3Y55.51%

5

5. Dividend

5.1 Amount

  • XRX has a Yearly Dividend Yield of 3.97%.
  • In the last 3 months the price of XRX has falen by -29.09%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.67, XRX pays a better dividend. On top of this XRX pays more dividend than 97.06% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, XRX pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

  • The dividend of XRX decreases each year by -12.86%.
  • XRX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As XRX did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-12.86%
Div Incr Years0
Div Non Decr Years6
XRX Yearly Dividends per shareXRX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • The earnings of XRX are negative and hence is the payout ratio. XRX will probably not be able to sustain this dividend level.
DP-6.81%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
XRX Yearly Income VS Free CF VS DividendXRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

XEROX HOLDINGS CORP

NASDAQ:XRX (2/3/2026, 8:00:03 PM)

Premarket: 2.1 -0.07 (-3.23%)

2.17

-0.13 (-5.65%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)01-29
Earnings (Next)04-29
Inst Owners81.7%
Inst Owner Change-1.38%
Ins Owners7.6%
Ins Owner Change-0.52%
Market Cap277.85M
Revenue(TTM)7.02B
Net Income(TTM)-1.04B
Analysts46
Price Target3.91 (80.18%)
Short Float %24.53%
Short Ratio8
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly Dividend0.56
Dividend Growth(5Y)-12.86%
DP-6.81%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-69.66%
Min EPS beat(2)-199.01%
Max EPS beat(2)59.69%
EPS beat(4)1
Avg EPS beat(4)-282.35%
Min EPS beat(4)-892.08%
Max EPS beat(4)59.69%
EPS beat(8)1
Avg EPS beat(8)-166.17%
EPS beat(12)4
Avg EPS beat(12)-91.07%
EPS beat(16)6
Avg EPS beat(16)-75.19%
Revenue beat(2)0
Avg Revenue beat(2)-4.64%
Min Revenue beat(2)-4.65%
Max Revenue beat(2)-4.62%
Revenue beat(4)1
Avg Revenue beat(4)-3%
Min Revenue beat(4)-4.65%
Max Revenue beat(4)0.96%
Revenue beat(8)2
Avg Revenue beat(8)-2.85%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)4
Avg Revenue beat(16)-2.06%
PT rev (1m)-44.22%
PT rev (3m)-46.6%
EPS NQ rev (1m)-79.25%
EPS NQ rev (3m)-76.08%
EPS NY rev (1m)-152.85%
EPS NY rev (3m)-196.23%
Revenue NQ rev (1m)-1.53%
Revenue NQ rev (3m)-3.27%
Revenue NY rev (1m)2.75%
Revenue NY rev (3m)1.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.78
P/S 0.04
P/FCF 2.09
P/OCF 1.24
P/B 0.42
P/tB N/A
EV/EBITDA 15.14
EPS(TTM)-0.6
EYN/A
EPS(NY)0.78
Fwd EY36.02%
FCF(TTM)1.04
FCFY47.87%
OCF(TTM)1.75
OCFY80.62%
SpS54.84
BVpS5.14
TBVpS-19.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.62%
ROE -158.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.07%
FCFM 1.89%
ROA(3y)-8.9%
ROA(5y)-6.63%
ROE(3y)-87.49%
ROE(5y)-56.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.02%
GM growth 5Y-6.26%
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 6.1
Debt/FCF 31.93
Debt/EBITDA 15.15
Cap/Depr 27.49%
Cap/Sales 1.3%
Interest Coverage N/A
Cash Conversion 84.53%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.8
Altman-Z 1.11
F-Score3
WACC4.29%
ROIC/WACCN/A
Cap/Depr(3y)19.43%
Cap/Depr(5y)20.04%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.78%
EPS Next Y230.29%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
EPS Next 5YN/A
Revenue 1Y (TTM)12.88%
Revenue growth 3Y-0.4%
Revenue growth 5Y0%
Sales Q2Q%25.73%
Revenue Next Year8.62%
Revenue Next 2Y2.6%
Revenue Next 3Y1.51%
Revenue Next 5YN/A
EBIT growth 1Y-141.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year146.76%
EBIT Next 3Y29.11%
EBIT Next 5YN/A
FCF growth 1Y-71.52%
FCF growth 3Y9.25%
FCF growth 5Y-22.44%
OCF growth 1Y-56.16%
OCF growth 3Y12.1%
OCF growth 5Y-16.38%

XEROX HOLDINGS CORP / XRX FAQ

What is the ChartMill fundamental rating of XEROX HOLDINGS CORP (XRX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to XRX.


Can you provide the valuation status for XEROX HOLDINGS CORP?

ChartMill assigns a valuation rating of 6 / 10 to XEROX HOLDINGS CORP (XRX). This can be considered as Fairly Valued.


What is the profitability of XRX stock?

XEROX HOLDINGS CORP (XRX) has a profitability rating of 2 / 10.


What is the expected EPS growth for XEROX HOLDINGS CORP (XRX) stock?

The Earnings per Share (EPS) of XEROX HOLDINGS CORP (XRX) is expected to grow by 230.29% in the next year.